Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Seminars in Oncology|October 1, 1995
Weekly, outpatient paclitaxel and concurrent cranial irradiation in adults with brain tumors: preliminary results and promising directionsM J Glantz, H Choy, C M Kearns, et al.The Journal of Pediatrics|September 1, 1993
Disposition of recombinant human granulocyte colony-stimulating factor in children with severe chronic neutropeniaC M Kearns, W C Wang, N Stute, et al.Urology|September 1, 1990
Development and testing of second generation extracorporeal shock-wave lithotriptorF P Begun, R K Lawson, J E Cauley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humansL Gianni, C M Kearns, A Giani, et al.Seminars in Oncology|December 1, 1996
Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and responseM J Glantz, H Choy, W Akerley, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemanniiM J Egorin, D L Sentz, D M Rosen, et al.Journal of the National Cancer Institute|July 19, 1995
Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumorsM J Glantz, H Choy, C M Kearns, et al.Seminars in Oncology|October 1, 1995
Pharmacokinetics of paclitaxel and carboplatin in combinationC M Kearns, C P Belani, K Erkmen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomasM J Glantz, H Choy, C M Kearns, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancerC P Belani, C M Kearns, E G Zuhowski, et al.Pageof 3